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Background: Reports vary considerably concerning characteristics of patients who will respond to mobilizing
exercises or manipulation. The objective of this prospective cohort study was to identify characteristics of patients
with a changeable lumbar condition, i.e. presenting with centralization or peripheralization, that were likely to
benefit the most from either the McKenzie method or spinal manipulation.
Methods: 350 patients with chronic low back pain were randomized to either the McKenzie method or
manipulation. The possible effect modifiers were age, severity of leg pain, pain-distribution, nerve root involvement,
duration of symptoms, and centralization of symptoms. The primary outcome was the number of patients
reporting success at two months follow-up. The values of the dichotomized predictors were tested according
to the prespecified analysis plan.
Results: No predictors were found to produce a statistically significant interaction effect. The McKenzie
method was superior to manipulation across all subgroups, thus the probability of success was consistently in
favor of this treatment independent of predictor observed. When the two strongest predictors, nerve root
involvement and peripheralization, were combined, the chance of success was relative risk 10.5 (95% CI 0.71-155.43)
for the McKenzie method and 1.23 (95% CI 1.03-1.46) for manipulation (P = 0.11 for interaction effect).
Conclusions: We did not find any baseline variables which were statistically significant effect modifiers in predicting
different response to either McKenzie treatment or spinal manipulation when compared to each other. However, we
did identify nerve root involvement and peripheralization to produce differences in response to McKenzie treatment
compared to manipulation that appear to be clinically important. These findings need testing in larger studies.
Trial registration: Clinicaltrials.gov: NCT00939107
Keywords: Low back pain, McKenzie, Spinal manipulation, Predictive value, Effect modificationBackground
The most recent published guidelines for the treatment of
patients with persistent non-specific low back pain (NSLBP)
recommend a program focusing on self-management
after initial advice and information. These patients should
also be offered structured exercises tailored to the individ-
ual patient and other modalities such as spinal manipula-
tion [1,2].* Correspondence: tom.petersen@suf.kk.dk
1Back Center Copenhagen, Copenhagen, Denmark
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unless otherwise stated.Previous studies have compared the effect of the
McKenzie-method, also known as Mechanical Diagnosis
and Therapy (MDT), with that of spinal manipulation (SM)
in heterogeneous populations of patients with acute and
subacute NSLBP and found no difference in outcome [3,4].
Recently, the need for studies testing the effect of treat-
ment strategies for subgroups of patients with NSLBP in
primary care has been emphasized in consensus-papers
[5,6] as well as the current European guidelines [7], based
on the hypothesis that subgroup analyses, preferably com-
plying with the recommendations of “Prognostic Factorl. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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most effective management strategies. Although initial
data show promising results, there is presently insufficient
evidence to recommend specific methods of subgrouping
in primary care [1,9].
Three randomized studies, comprising patients with
predominantly acute or subacute low back pain (LBP),
have tested the effects of MDT versus SM in a subgroup of
patients that presented with centralization of symptoms or
directional preference (favorable response to end range
motions) during physical examination [10-12]. The conclu-
sions drawn from these studies were not in concurrence
and the usefulness was limited by a low methodological
quality.
Our recent randomized study, comprising patients with
predominantly chronic LBP (CLBP), found a marginally
better overall effect of MDT versus SM in an equivalent
group [13]. In order to pursue the idea of subgrouping
further, it was part of the study plan to explore predictors
based on patient characteristics that could assist the clin-
ician in targeting the most favorable treatment to the indi-
vidual patient.
The objective of this study was to identify subgroups
of patients with predominantly CLBP, presenting with
centralization or peripheralization, which were likely to




The present study is a secondary analysis of a previously
published randomized controlled trial [13]. We recruited
350 patients from September 2003 through May 2007 at
an outpatient back care centre in Copenhagen, Denmark.
Patients
Patients were referred from primary care physicians for
treatment of persistent LBP. Eligible patients were be-
tween 18 and 60 years of age, suffering from LBP with
or without leg pain for a period of more than 6 weeks, able
to speak and understand the Danish language, and fulfilled
the clinical criteria for centralization or peripheralization
of symptoms during initial screening. Centralization was
defined as the abolition of symptoms in the most distal
body region (such as the foot, lower leg, upper leg, but-
tocks, or lateral low back) and peripheralization was de-
fined as the production of symptoms in a more distal body
region. These findings have previously been found to have
acceptable degree of inter-tester reliability (Kappa value
0.64) [14]. The initial screening was performed prior to
randomization by a physical therapist with a diploma in
the MDT examination system. Patients were excluded if
they were free of symptoms at the day of inclusion, dem-
onstrated positive non-organic signs [15], or if seriouspathology, i.e. severe nerve root involvement (disabling
back or leg pain in combination with progressive distur-
bances in sensibility, muscle strength, or reflexes), osteo-
porosis, severe spondylolisthesis, fracture, inflammatory
arthritis, cancer, or referred pain from the viscera, was sus-
pected based on physical examination and/or magnetic
resonance imaging. Other exclusion criteria were applica-
tion for disability pension, pending litigation, pregnancy,
co-morbidity, recent back surgery, language problems, or
problems with communication including abuse of drugs or
alcohol.
The trial population had predominantly CLBP lasting
on average 95 weeks (SD 207), mean age was 37 years
(SD10), mean level of back and leg pain was 30 (SD
11.9) on a Numeric Rating Scale ranging from 0 to 60,
and mean level of disability was 13 (SD 4.8) on Roland
Morris Disability Questionnaire (0-23). Our method of
pain measurement reflects that back pain is often a fluctu-
ating condition where pain location and severity might
vary on a daily basis. Therefore, a validated comprehensive
pain questionnaire [16] was used in order to guarantee
that all aspects of back and leg pain intensity were re-
corded. The scales are outlined in the legend to Table 1.
After baseline measures were obtained, randomisation
was carried out by a computer-generated list of random
numbers in blocks of ten using sealed opaque envelopes.Ethics
Ethical approval of the study was granted by Copenhagen
Research Ethics Committee, file no 01-057/03. All patients
received written information about the study and gave
their written consent prior to participation.Treatments
The practitioners performing the treatments had no
knowledge of the results of the initial screening. The treat-
ment programs were designed to reflect daily practice as
much as possible. Detailed information on these programs
have been published earlier [13].
The MDT treatment was planned individually follow-
ing the therapist’s pre-treatment physical assessment.
Specific manual vertebral mobilization techniques including
high velocity thrust were not allowed. An educational book-
let describing self care [17] or a “lumbar roll” for correction
of the seated position was sometimes provided to the pa-
tient at the discretion of the therapist. In the SM treatment,
high velocity thrust was used in combination with other
types of manual techniques. The choice of combination of
techniques was at the discretion of the chiropractor. Gen-
eral mobilizing exercises, i.e. self-manipulation, alternating
lumbar flexion/extension movements, and stretching, were
allowed but not specific exercises in the directional prefer-
ence. An inclined wedged pillow for correction of the
Table 1 Comparison of distribution of baseline variables between groups
McKenzie group Manipulation group
Number of patients % Total Number of patients % Total RR (95% CI) P-value
Age
Below 40 107 61.6% 175 117 66.9% 175 0.91 (0.78-1.07) 0.27
Gender
Male 72 41.1% 175 83 47.4% 175 0.87 (0.69-1.10) 0.24
Duration of symptoms
More than a year 55 31.4% 175 54 30.9% 175 1.01 (0.88-1.16) 0.91
Disability
Mild/moderate¤ 64 36.6% 175 68 38.9% 175 0.94 (0.72-1.23) 0.66
Leg pain¤¤
Moderate/severe 92 52.6% 175 87 49.7% 175 1.06 (0.85-1.32) 0.59
Back pain¤¤
Mild 19 10.9% 175 24 13.7% 175 0.79 (0.45-1.39) 0.42
Sickleave past year
Six days or less¤¤¤ 85 52.1% 163 87 52.7% 165 0.99 (0.80-1.20) 0.92
Nerve root involvement
Yes* 18 10.3% 175 16 9.1% 175 1.13 (0.59-3.13) 0.72
Pain below the knee
Yes 88 50.3% 175 102 58.3% 175 0.86 (0.71-1.05) 0.13
Expectations to recovery
High** 84 52.5% 160 68 49.3% 138 1.07 (0.85-1.33) 0.58
Expectations to work
High*** 63 37.1% 170 76 43.9% 173 0.84 (0.65-1.09) 0.20
Pain response
Centralization§ 151 86.3% 175 156 89.1% 175 0.97 (0.89-1.05) 0.42
N = 350 except Sick leave past year (N = 328), Expectations to recovery (N = 298) and Expectations to work (N = 343).
RR = Relative Risks (95% confidence intervals) show the chance of having the characteristics in the McKenzie group compared to the Manipulation group (i.e. the
chance of having pain below the knee in the McKenzie group compared to the Manipulation group).
¤The total score on Roland Morris were divided into mild (0-5), moderate (6-11), or severe (12-23) disability.
¤¤Each of the back and leg pain questionnaires included 3 separate 11 point box scales (0-30) comprising the following items: pain at the moment, the worst
pain within the past two weeks, and the average level of pain within the last two weeks. For each questionnaires, these summed to a total score ranging from 0 points
(no back or leg pain at all) to 30 points (worst possible back or leg pain). The total score was divided into mild (0-10), moderate (11-20), or severe (21-30) pain.
¤¤¤Number of days reported by the patient. Dichotomized into high/low risk groups according to scores above/below the median of 6 found in the sample.
*Based on presence of dominant leg pain in any distribution as well as the following clinical signs of nerve root pain: positive straight leg raise test of less than 60
degrees that reproduced leg pain in combination with diminished reflexes, and/or muscle weakness in a myotomal or dermatomal pattern, and/or
sensory disturbances.
**Scored before the initiation of third treatment on an 11-point box scale. 0 indicates I expect no improvement at all; 10, I am certain that I will improve. Dichotomized
into high/low risk groups according to the median scores: high (8 or above), low (below 8).
***Measured on an 11 point box scale regarding expectations about coping with work tasks in six weeks time (endpoints ‘No trouble at all’ and ‘So much trouble
that I won’t be able to do my job at all’). Dichotomized into high/low risk groups according to the median scores low (3 or above); high (below 3).
§Movement of symptoms from a distal to a more proximal location during pre-randomization physical screening.
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practor believed this to be indicated.
In both treatment groups, patients were informed thor-
oughly of the results of the physical assessment, the benign
course of back pain, and the importance of remaining
physically active. Guidance on proper back care was also
given. In addition, all patients were provided with a Danish
version of “The Back Book” which previously has been
shown to have beneficial effect on patients’ beliefs about
back pain [18]. A maximum of 15 treatments for a periodof 12 weeks were given. If considered necessary by the
treating clinician, patients were educated in an individual
program of self-administered mobilizing, stretching, sta-
bilizing, and/or strengthening exercises at the end of the
treatment period. Treatments were performed by clini-
cians with several years of experience. Patients were
instructed to continue their individual exercises at home
or at a gym for a minimum of two months after comple-
tion of the treatment at the back center. Because the pa-
tients suffered predominantly from CLBP we expected
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for the patients to experience the full effect of the inter-
vention. Patients were encouraged not to seek any other
kind of treatment during this two months period of self-
administered exercises.
Outcome measures
The primary outcome was the proportion of patients
reporting success at follow-up two months after end of
treatment. Treatment success was defined as a reduction
of at least 5 points or a final score below 5 points on the
23-item modified Roland Morris Disability Questionnaire
(RMDQ) [19]. A validated Danish version of RMDQ was
used [20]. The definition of treatment success was based
on the recommendations by others [21,22]. A sensitivity
analysis using 30% relative improvement on RMDQ as
definition of success was also performed. In accordance
with the protocol [13], we considered a relative between-
group difference of 15% in the number of patients with
successful outcome to be minimal clinically important in
our analysis of interaction.
Prespecified predictor variables
In order to reduce the likelihood of spurious findings
[23], we restricted the number of candidate effect modi-
fiers in the dataset to six. To increase the validity of our
findings, a directional hypothesis was established for each
variable according to the recommendations of Sun et al.
[24] Four baseline variables have previously been suggested
in randomized studies to be predictive of long term good
outcome in patients with persistent LBP following MDT
in comparison with strengthening training: centralization
[25,26], or following SM in comparison to physiotherapy
or treatment chosen by a general practitioner: age below
40 years [27,28], duration of symptoms more than 1 year
[27], and pain below the knee [29]. As recommended by
others [30], another two variables were added based on
the participating experienced clinicians’ judgments of
which characteristics they would expect to predict good
outcome from their treatment compared to the other. The
additional variables prioritized by the physiotherapists in
the MDT group were signs of nerve root involvement and
substantial leg pain. The additional variables prioritized by
the chiropractors in the SM group were no signs of nerve
root involvement and not substantial leg pain.
In a supplementary analysis, we took the opportunity
to explore whether the inclusion of further six baseline
variables, assumed to have prognostic value for good
outcome in either of the treatment groups, would appear
to have an effect modifying effect as well. To our know-
ledge, no further variables from previous one arm stud-
ies have been reported to have prognostic value of long
term good outcome in patients with persistent LBP fol-
lowing MDT, whereas three variables have been reportedto have prognostic value following SM: male gender [28],
mild disability [28], and mild back pain [28]. Another
three variables were agreed upon by the clinicians to be
included in the supplementary analysis as they were as-
sumed by experience from clinical practice to have prog-
nostic value for good outcome regardless of treatment
with MDT or SM: low number of days on sick leave past
year, high patient expectations to recovery, and high pa-
tient expectations about coping with work tasks six weeks
after initiation of treatment.
Dichotomization of possible predictor variables were
made to allow for comparisons to be made with those of
earlier studies. In cases where no cut off values could be
found in the literature, dichotomization was performed
above/below the median found in the sample. Defini-
tions of variables are presented in the legend to Table 1.
Statistics
The entire intention-to-treat (ITT) population was used
in all the analyses. The last score was carried forward for
subjects with missing two months RMDQ scores (7 pa-
tients in the MDT group and 14 patients in the SM
group). In addition, a post hoc per protocol analysis was
carried out comprising only those 259 patients that com-
pleted the full treatment. The analysis plan was agreed
in advance by the trial management group.
The possible predictors were dichotomized and the
chance of success was investigated by estimating the
relative risk (RR) of success in each of the two strata.
The impact of the investigated predictors was estimated
by comparing the chance of success between the treat-
ment groups when divided into the two strata. To test
for treatment effect modification of the predictors we
performed chi-squared tests for interaction between
intervention and the two different strata for each of the
predictors. This is basically the same as an interaction
from a regression model. Confidence intervals were also
inspected for potential clinically important effects.
Following the univariate analysis, a multivariate ana-
lysis was planned including effect modifiers with a p-value
below 0.1.
Results
Participants were similar with respect to socio-demographic
and clinical characteristics at baseline in the treatment
groups. An overview of the distribution of the included di-
chotomized variables at baseline is provided in Table 1.
No differences were found between the treatment groups.
Overall, the post hoc per protocol analysis did not pro-
duce outcome results that were different from the results
of the ITT analysis and therefore only the results of the
ITT analysis will be reported.
Figure 1 presents the distribution of predictors with
regards to effect modification in the MDT group versus
Figure 1 Treatment effect modified by predictors. The top point estimate and confidence intervals indicate overall effect without subgrouping.
Subsequent pairs of point estimates and confidence intervals show the chances of treatment success following MDT vs spinal manipulation in
six subgroups.
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was superior to that of SM. Because of low sample size,
confidence intervals were wide and none of the predictors
had a statistically significant treatment modifying effect.
The predictors with a clinically important potential ef-
fect in favor of MDT compared to SM were nerve
root involvement (28% higher proportion of patients
with success when nerve root involvement was present
than when absent) and peripheralization of symptoms
(17% higher proportion of patients with success in case of
peripheralization than in case of centralization). If present,
nerve root involvement increased the chance of success
following MDT 2.31 times compared to that of SM
and 1.22 times if not present. This means that for the
subgroup of patients with nerve root involvement re-
ceiving MDT, compared to those receiving SM, the
relative effect appeared to be 1.89 times (2.31/1.22, P =
0.118) higher than for the subgroup with no nerve root
involvement.
Figure 2 presents the modifying effect of a composite
of the two predictors with a clinically important poten-
tial effect. If signs of nerve root involvement and
peripheralization were present at baseline, the chance
of success with MDT compared to SM appeared 8.5 times
higher than for the subgroup with no centralization andFigure 2 Impact of the two clinically important predictors combinednerve root involvement. The number of patients was very
small and the differences were not statistically significant
(P = 0.11).
None of the prognostic candidate variables explored in
the supplementary analysis appeared to have any clinically
important modifying effect (Additional file 1: Table S1).
The results from the sensitivity analysis using 30%
relative improvement on RMDQ as definition of success
were not markedly different from those presented above
(Additional file 2: Table S2).
Discussion
To our knowledge, this is the first study trying to identify
effect modifiers when two mobilizing strategies, i.e. MDT
and SM, are compared in a sample of patients with as
changeable condition characterized by centralization or
peripheralization.
Our study found that none of the potential effect mod-
ifiers were able to statistically significantly increase the
overall effect of MDT compared to that of SM. However,
the between-group difference for two of the variables
exceeded our clinically important success-rate of 15% in
number of patients with successful outcome, so our study
is likely to have missed a true effect and, in that sense, did
not have a large enough sample size.on treatment effect. RR = Relative Risk with Yates correction.
Petersen et al. BMC Musculoskeletal Disorders  (2015) 16:74 Page 6 of 7The most apparent finding is that in our small subgroup
of patients with signs of nerve root involvement, the rela-
tive chance of success appeared 1.89 times (2.31/1.22)
higher than in patients with no nerve root involvement
when treated with MDT, compared to those treated with
SM. The difference was in the expected direction.
Although not statistically significant in our small sam-
ple, the variable peripheralization exceeded our clinically
important success-rate of 15%, but was found not to be in
the expected direction. No previous studies have assessed
the effect modification of centralization or peripheralization
in patients with CLBP. The RCT by Long et al. [25,26]
concluded that patients with directional preference, in-
cluding centralization, fared better 2 weeks after baseline
than patients with no directional preference when treated
with MDT in comparison with strengthening training.
However, the outcome among peripheralizers was not re-
ported, so the poor outcome reported in patients with no
directional preference might be related to the subgroup of
patients who responded with no change in symptoms dur-
ing initial examination and not to those that responded
with peripheralization. An alternative explanation might
be that the effect modifying impact of centralization or
peripheralization on MDT is dependent on the control
treatment. Our findings suggest that future studies in this
area need to involve predictive value of peripheralization
as well as centralization.
When a composite of the two most promising predic-
tors, peripheralization and signs of nerve root involvement,
were present at baseline, the relative chance of success
with MDT compared to SM appeared 8.5 times higher
than for the subgroup with no centralization and nerve
root involvement. The number of patients was very small
and the confidence interval was wide. Therefore only a
preliminary conclusion about interaction can be drawn
and it calls for a validation in future studies.
In our study, there appeared to be no characteristic by
which SM had better results compared to MDT. Thus,
we could not support the results of two studies with a
similar design as ours (two arms, sample of patients with
persistent LBP, and outcome reported in terms of reduc-
tion of disability at long term follow up) [27,29]. In those
studies, Nyiendo et al. [29] found a modifying effect of
leg pain below knee on treatment by SM compared to
that of the general practitioner six months after baseline,
and Koes et al. [27] found a modifying effect of age below
40 years and symptom duration more than a year on treat-
ment by SM compared to that of physiotherapy 12 months
after baseline. However, results from those, as well as
other previous RCTs comprising patients with persistent
LBP, have supported our findings regarding the lack
of effect modification of age [27,29,31], sex [29,31], baseline
disability [27,29,31], and duration of symptoms [31], on SM
when measured on reduction of disability 6-12 monthsafter randomization. So, although evidence is emerging in
patients with acute LBP regarding subgroup characteris-
tics predictive of better results from SM compared to
other types of treatment [32], we are still in the dark with
respect to patients with persistent LBP.
The usefulness of choosing a criterion for success by
combining an improvement of at least 5 points or an ab-
solute score below 5 points on RMDQ is debatable. A
total of 22 patients were considered successful based on
score below 5 at follow up without having an improve-
ment of at least 5 points. We therefore performed a sen-
sitivity analysis using a relative improvement of at least
30% as criterion of success as recommended by others
[22] (see Additional file 2: Table S2). As a result, the per-
centage of patients with successful outcome in the MDT
group remained the same whereas 4 more patients were
defined as successes in the SM group. Overall the sensi-
tivity analysis did not produce outcome results that were
markedly different from those of the primary analysis
and therefore only those have been discussed above.
Strengths and limitations
This study used data from a RCT, whereas many others
have used single arm designs not suitable for the purpose
of evaluating treatment effect modification [33]. In ac-
cordance with the recommendations by the PROGRESS
group [8] we prespecified the possible predictors and also
the direction of the effect. Furthermore, we limited the
number of predictors included in order to minimize the
chance of spurious findings.
The main limitation in secondary studies to previously
conducted RCTs is that they are powered to detect overall
treatment effect rather that effect modification. In recog-
nition of the post hoc nature of our analysis, reflected in
wide confidence intervals, we must emphasize that our
findings are exploratory and require formal testing in a
larger sample size.
Conclusions
In all subgroups, the probability of success with MDT was
superior to that of SM. Although not statistically significant,
the presence of nerve root involvement and peripheralization
appear promising effect modifiers in favour of MDT.
These findings need testing in larger studies.
Additional files
Additional file 1: Table S1. Treatment effect modified by prognostic
variables.
Additional file 2: Table S2. Results of the sensitivity analysis. Treatment
effect modified by predictors when 30% relative improvement on RMDQ
as definition of success was used.
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